Abstract:Inflammation is the preceding condition for the development of mild and severe pathological conditions, including various forms of osteopenia, cancer, metabolic syndromes, neurological disorders, atherosclerosis, cardiovascular, lung diseases, etc., in human and animals. The inflammatory status is induced by multifarious intracellular signaling cascades, where cytokines, chemokines, arachidonic acid metabolites, adhesion molecules, immune cells and other components foster a "slow burn" at a local or systemic level. Assuming that countering inflammation limits the development of inflammation-based diseases, a series of new side-effects-free therapies was assessed in experimental and domestic animals. Within the targets of the drug candidates for quenching inflammation, an archetypal autophagic gear, the p62/sqstm1 protein, has currently earned attention from researchers. Intracellular p62 has been recently coined as a multi-task tool associated with autophagy, bone remodeling, bone marrow integrity, cancer progression, and the maintenance of systemic homeostasis. Accordingly, p62 can act as an effective suppressor of inflamm-aging, reducing oxidative stress and proinflammatory signals. Such an operational schedule renders this protein an effective watchdog for degenerative diseases and cancer development in laboratory and pet animals. This review summarizes the current findings concerning p62 activities as a molecular hub for cell and tissues metabolism and in a variety of inflammatory diseases and other pathological conditions. It also specifically addresses the applications of exogenous p62 (DNA plasmid) as an anti-inflammatory and homeostatic regulator in the treatment of osteoporosis, metabolic syndrome, age-related macular degeneration and cancer in animals, and the possible application of p62 plasmid in other inflammation-associated diseases.

Selective Autophagy Receptor p62/SQSTM1, a Pivotal Player in Stress and Aging

The Homeostasis of p62/SQSTM1 Short Isoform Regulates Selective Autophagy

p62/SQSTM1: A Missing Link between Protein Aggregates and the Autophagy Machinery

P62/sqstm1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators.

Requirement for P62 Acetylation in the Aggregation of Ubiquitylated Proteins under Nutrient Stress

From autophagy to mitophagy: the roles of P62 in neurodegenerative diseases

Autophagy Facilitates Age-Related Cell Apoptosis—a New Insight from Senile Cataract

Oxidation of SQSTM1/p62 mediates the link between redox state and protein homeostasis

p62 links the autophagy pathway and the ubiqutin–proteasome system upon ubiquitinated protein degradation

P62/SQSTM1 beyond Autophagy: Physiological Role and Therapeutic Applications in Laboratory and Domestic Animals

S-acylation regulates SQSTM1/p62-mediated selective autophagy

S-acylation of P62 Promotes P62 Droplet Recruitment into Autophagosomes in Mammalian Autophagy.

The role of sequestosome 1/p62 protein in amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis

ZZ-dependent Regulation of P62/sqstm1 in Autophagy

p62-mediated phase separation at the intersection of the ubiquitin-proteasome system and autophagy

Role of p62/SQSTM1 beyond autophagy: a lesson learned from drug-induced toxicity in vitro

The Receptor Proteins: Pivotal Roles in Selective Autophagy

Interaction domains of p62: a bridge between p62 and selective autophagy.

p62/SQSTM1-droplet serves as a platform for autophagosome formation and anti-oxidative stress response

p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death

Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression (Review)